Ran GTPase: A Key Player in Tumor Progression and Metastasis

Ran (Ras-related nuclear protein) GTPase is a member of the Ras superfamily. Like all the GTPases, Ran cycles between an active (GTP-bound) and inactive (GDP-bound) state. However, Ran lacks the CAAX motif at its C-terminus, a feature of other small GTPases that ensures a plasma membrane localizatio...

Full description

Bibliographic Details
Main Authors: Zied Boudhraa, Euridice Carmona, Diane Provencher, Anne-Marie Mes-Masson
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-05-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fcell.2020.00345/full
_version_ 1830284045417709568
author Zied Boudhraa
Zied Boudhraa
Euridice Carmona
Euridice Carmona
Diane Provencher
Diane Provencher
Diane Provencher
Anne-Marie Mes-Masson
Anne-Marie Mes-Masson
Anne-Marie Mes-Masson
author_facet Zied Boudhraa
Zied Boudhraa
Euridice Carmona
Euridice Carmona
Diane Provencher
Diane Provencher
Diane Provencher
Anne-Marie Mes-Masson
Anne-Marie Mes-Masson
Anne-Marie Mes-Masson
author_sort Zied Boudhraa
collection DOAJ
description Ran (Ras-related nuclear protein) GTPase is a member of the Ras superfamily. Like all the GTPases, Ran cycles between an active (GTP-bound) and inactive (GDP-bound) state. However, Ran lacks the CAAX motif at its C-terminus, a feature of other small GTPases that ensures a plasma membrane localization, and largely traffics between the nucleus and the cytoplasm. Ran regulates nucleo-cytoplasmic transport of molecules through the nuclear pore complex and controls cell cycle progression through the regulation of microtubule polymerization and mitotic spindle formation. The disruption of Ran expression has been linked to cancer at different levels – from cancer initiation to metastasis. In the present review, we discuss the contribution of Ran in the acquisition of three hallmarks of cancer, namely, proliferative signaling, resistance to apoptosis, and invasion/metastasis, and highlight its prognostic value in cancer patients. In addition, we discuss the use of this GTPase as a therapeutic target in cancer.
first_indexed 2024-12-19T03:12:26Z
format Article
id doaj.art-9ed14a39ad3648e085253a9da3884efd
institution Directory Open Access Journal
issn 2296-634X
language English
last_indexed 2024-12-19T03:12:26Z
publishDate 2020-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cell and Developmental Biology
spelling doaj.art-9ed14a39ad3648e085253a9da3884efd2022-12-21T20:37:59ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2020-05-01810.3389/fcell.2020.00345526872Ran GTPase: A Key Player in Tumor Progression and MetastasisZied Boudhraa0Zied Boudhraa1Euridice Carmona2Euridice Carmona3Diane Provencher4Diane Provencher5Diane Provencher6Anne-Marie Mes-Masson7Anne-Marie Mes-Masson8Anne-Marie Mes-Masson9Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), Montreal, QC, CanadaInstitut du Cancer de Montréal (ICM), Montreal, QC, CanadaCentre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), Montreal, QC, CanadaInstitut du Cancer de Montréal (ICM), Montreal, QC, CanadaCentre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), Montreal, QC, CanadaInstitut du Cancer de Montréal (ICM), Montreal, QC, CanadaDivision of Gynecologic Oncology, Université de Montréal, Montreal, QC, CanadaCentre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), Montreal, QC, CanadaInstitut du Cancer de Montréal (ICM), Montreal, QC, CanadaDepartment of Medicine, Université de Montréal, Montreal, QC, CanadaRan (Ras-related nuclear protein) GTPase is a member of the Ras superfamily. Like all the GTPases, Ran cycles between an active (GTP-bound) and inactive (GDP-bound) state. However, Ran lacks the CAAX motif at its C-terminus, a feature of other small GTPases that ensures a plasma membrane localization, and largely traffics between the nucleus and the cytoplasm. Ran regulates nucleo-cytoplasmic transport of molecules through the nuclear pore complex and controls cell cycle progression through the regulation of microtubule polymerization and mitotic spindle formation. The disruption of Ran expression has been linked to cancer at different levels – from cancer initiation to metastasis. In the present review, we discuss the contribution of Ran in the acquisition of three hallmarks of cancer, namely, proliferative signaling, resistance to apoptosis, and invasion/metastasis, and highlight its prognostic value in cancer patients. In addition, we discuss the use of this GTPase as a therapeutic target in cancer.https://www.frontiersin.org/article/10.3389/fcell.2020.00345/fullRan GTPasecancermetastasissurvivalproliferation
spellingShingle Zied Boudhraa
Zied Boudhraa
Euridice Carmona
Euridice Carmona
Diane Provencher
Diane Provencher
Diane Provencher
Anne-Marie Mes-Masson
Anne-Marie Mes-Masson
Anne-Marie Mes-Masson
Ran GTPase: A Key Player in Tumor Progression and Metastasis
Frontiers in Cell and Developmental Biology
Ran GTPase
cancer
metastasis
survival
proliferation
title Ran GTPase: A Key Player in Tumor Progression and Metastasis
title_full Ran GTPase: A Key Player in Tumor Progression and Metastasis
title_fullStr Ran GTPase: A Key Player in Tumor Progression and Metastasis
title_full_unstemmed Ran GTPase: A Key Player in Tumor Progression and Metastasis
title_short Ran GTPase: A Key Player in Tumor Progression and Metastasis
title_sort ran gtpase a key player in tumor progression and metastasis
topic Ran GTPase
cancer
metastasis
survival
proliferation
url https://www.frontiersin.org/article/10.3389/fcell.2020.00345/full
work_keys_str_mv AT ziedboudhraa rangtpaseakeyplayerintumorprogressionandmetastasis
AT ziedboudhraa rangtpaseakeyplayerintumorprogressionandmetastasis
AT euridicecarmona rangtpaseakeyplayerintumorprogressionandmetastasis
AT euridicecarmona rangtpaseakeyplayerintumorprogressionandmetastasis
AT dianeprovencher rangtpaseakeyplayerintumorprogressionandmetastasis
AT dianeprovencher rangtpaseakeyplayerintumorprogressionandmetastasis
AT dianeprovencher rangtpaseakeyplayerintumorprogressionandmetastasis
AT annemariemesmasson rangtpaseakeyplayerintumorprogressionandmetastasis
AT annemariemesmasson rangtpaseakeyplayerintumorprogressionandmetastasis
AT annemariemesmasson rangtpaseakeyplayerintumorprogressionandmetastasis